These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6419798)

  • 1. Incidence of immune responses following 102 infusions of autoplex in 18 hemophilic patients with antibody to factor VIII.
    Laurian Y; Girma JP; Lambert T; Meyer D; Larrieu MJ
    Blood; 1984 Feb; 63(2):457-62. PubMed ID: 6419798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Articular and muscular hemorrhages in hemophilia A with anti-factor VIII antibodies. Treatment with selected batches of PPSB (factor IX concentrate)].
    Verroust F; Moussard C; Allain JP
    Presse Med; 1985 May; 14(19):1073-6. PubMed ID: 3158962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of an activated factor IX complex (Autoplex) in the management of haemarthroses in haemophiliacs with antibodies to factor VIII.
    Aronstam A; McLellan DS; Mbatha PS; Wassef M
    Clin Lab Haematol; 1982; 4(3):231-8. PubMed ID: 6816500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIII inhibitor treatment with high doses of F VIII.
    Stenbjerg S; Ingerslev J; Zachariae E
    Thromb Res; 1984 Jun; 34(6):533-9. PubMed ID: 6429891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of patients with hemophilia A having antibodies to factor VIII].
    Lopaciuk S; Ziemski JM
    Acta Haematol Pol; 1979; 10(2):115-22. PubMed ID: 474044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prothrombin complex concentrates on factor VIII inhibitor levels.
    Kasper CK
    Blood; 1979 Dec; 54(6):1358-68. PubMed ID: 508942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inhibitor Coagulant Complex (Autoplex) for treatment of factor VIII inhibitors in hemophilia.
    Abildgaard CF; Penner JA; Watson-Williams EJ
    Blood; 1980 Dec; 56(6):978-84. PubMed ID: 6777002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII.
    Lusher JM; Blatt PM; Penner JA; Aledort LM; Levine PH; White GC; Warrier AI; Whitehurst DA
    Blood; 1983 Nov; 62(5):1135-8. PubMed ID: 6414555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-A, non-B hepatitis in hemophilic patients with inhibitor treated with activated prothrombin complex concentrates: lack of correlation with an antigen possibly related to non-A, non-B hepatitis.
    Allain JP; Duermeijer W; Hellings JA; Gazengel C; Laurian Y; Verroust F
    Vox Sang; 1984; 47(1):47-53. PubMed ID: 6204454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial.
    Sjamsoedin LJ; Heijnen L; Mauser-Bunschoten EP; van Geijlswijk JL; van Houwelingen H; van Asten P; Sixma JJ
    N Engl J Med; 1981 Sep; 305(13):717-21. PubMed ID: 6790990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lingual hemorrhage in a patient with hemophilia A complicated by a high titer inhibitor. Management by continuous infusion of monoclonal antibody-purified factor VIII.
    Gordon EM; Mungo R; Goldsmith JC
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):107-10. PubMed ID: 8447550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with polyelectrolyte-fractionated porcine factor VIII concentrate in the treatment of hemophiliacs with antibodies to factor VIII.
    Kernoff PB; Thomas ND; Lilley PA; Matthews KB; Goldman E; Tuddenham EG
    Blood; 1984 Jan; 63(1):31-41. PubMed ID: 6418234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-factor VIII anamnesis after factor IX complex.
    Palascak JE; Shapiro SR
    N Engl J Med; 1977 Dec; 297(25):1403. PubMed ID: 927458
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterogeneity of autoantibodies to factor VIII: differences in specificity for apparently distinct antigenic determinants of factor VIII coagulant protein.
    Croissant MP; Zuzel M; Allain JP
    Blood; 1983 Jul; 62(1):133-40. PubMed ID: 6190519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized study of factor VIII or prothrombin complex concentrate infusions in children with haemophilia and antibodies to factor VIII.
    Ekert H; Price DA; Lane JL; Dean FL
    Aust N Z J Med; 1979 Jun; 9(3):241-4. PubMed ID: 288389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early experience with the use of anti-inhibitor coagulant complex to treat bleeding in hemophiliacs with inhibitors to factor VIII.
    Kantrowitz JL; Lee ML; McClure DA; Kingdon HS; Thomas WR
    Clin Ther; 1987; 9(4):405-19. PubMed ID: 3111706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of non-activated prothrombin concentrate in the management of haemophilia A with factor VIII antibodies.
    Price DA; d'Souza S; Ekert H
    Aust N Z J Med; 1977 Jun; 7(3):286-90. PubMed ID: 269689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bilateral prosthesis of the knee in a hemophilia A patient with an inhibitor].
    Lauroua P; Barbier F; Dieu P; Dumora D; Moulinier J
    Ann Fr Anesth Reanim; 1986; 5(2):154-6. PubMed ID: 3089078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seventeen years' experience with Autoplex/Autoplex T: evaluation of inpatients with severe haemophilia A and factor VIII inhibitors at a major haemophilia centre.
    White GC
    Haemophilia; 2000 Sep; 6(5):508-12. PubMed ID: 11012694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.